Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers

NCT00724997 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Human Influenza

Interventions

BIOLOGICAL: GHB01L1

Sponsor

AVIR Green Hills Biotechnology AG